Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

TARS

Kedudukan dalam Saham #4712
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Harga Saham
$68.50
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$3.21B
Perubahan (1 hari)
-3.51%
Perubahan (1 tahun)
-6.07%
Negara
US
Perdagangan Tarsus Pharmaceuticals, Inc. (TARS)

Kategori

Healthcare
Margin Operasi untuk Tarsus Pharmaceuticals, Inc. (TARS)
Margin Operasi pada October 2026 TTM: -8.00%
Menurut laporan kewangan dan harga saham terkini Tarsus Pharmaceuticals, Inc., margin operasi semasa (TTM) ialah -8.00%. Pada akhir 2023, margin operasi syarikat ialah -820.53%.
Sejarah Margin Operasi untuk Tarsus Pharmaceuticals, Inc. dari 2018 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Ubah
2026 (TTM) -8.00% -87.86%
2024 -65.90% -91.97%
2023 -820.53% 237.78%
2022 -242.92% 1,039.40%
2021 -21.32% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
Margin Operasi untuk syarikat serupa atau pesaing
Syarikat Margin Operasi Perbezaan Margin Operasi Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -104.82%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -81.37%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.57% -103.20%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -103.60%
NL
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.